KY-02327 (acetate)
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-124156A-5MG | 5 mg | 584,00 | Add | |
| HY-124156A-10MG | 10 mg | 964,00 | Add | |
| HY-124156A-25MG | 25 mg | 1'914,00 | Add | |
| HY-124156A-50MG | 50 mg | 3'053,00 | Add | |
| HY-124156A-100MG | 100 mg | 4'574,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
KY-02327 acetate, a metabolically stabilized KY-02061 analog, is a potent Dishevelled (Dvl)-CXXC5 interaction inhibitor. KY-02327 acetate shows an activating effect on the Wnt/β-catenin pathway, resulting in promotion of osteoblast differentiation[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Metabolic Disease, Stem Cell/Wnt |
| Format | Solubility: DMSO : 140 mg/mL (ultrasonic;warming;heat to 80°C);H2O : ≥ 160 mg/mL |
| Grade | Clinical information: No Development Reported |
| Purity | 99.35% |
| Molecular Formula | C22H31N3O6 |
| Molecular Weight | 433.5 |
| Storage Conditions | 4°C (Powder, sealed storage, away from moisture and light) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
